by Chirag K. Kumar, Nathan C. Lo Measles and other vaccine-preventable diseases are re-emerging worldwide in locations where they were once eliminated. Targeted policy interventions in the locations at greatest risk may be an effective strategy to curb this public health threat. Measles and other vaccine-preventable diseases are re-emerging worldwide in locations where they were once eliminated. In this Perspective, Chirag Kumar and Nathan Lo outline how and why targeted policy interventions in the locations at greatest risk may be an effective strategy to curb this public health threat.
An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhoea infection.
If we do not get this right, we may inadvertently cause a new sarcopenia epidemic while congratulating ourselves on solving obesity. The post GLP-1s Are Working — Now Medicine Needs to Measure What Matters appeared first on MedCity News .
The Department of Health and Social Care (DHSC) will consider the recommendation before a decision is made on any changes to the NHS MenB vaccination schedule.
For years, the healthcare industry treated data collection as the main challenge. The next phase is about interpretation, coordination, and operational usability. The post Building AI-Ready Public Health Data Systems for Faster, Safer Decisions appeared first on MedCity News .
Statement setting out the recommendation from the Joint Committee on Vaccination and Immunisation (JCVI) on meningococcal capsular group B (MenB) adolescent vaccination.
FDA has approved Lipfendra (enlicitide) as a treatment to be used with diet and exercise, to reduce low-density lipoprotein cholesterol (LDL-C) in adults with high cholesterol or who have an inherited type of high cholesterol called heterozygous familial hypercholesterolemia (HeFH).
Tens of thousands of cancer patients have rated the care they received from the NHS as nearly 9 out of 10, as NHS teams see and treat record numbers of people for the disease. The latest patient experience figures come as NHS cancer checks have reached nearly 3.4 million in a year – more than doubling in the last decade. The number of patients receiving cancer […]
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its 2025–26 Annual Report and Accounts highlighting a year of strong and consistent delivery as set out in the agency’s first Results and Forecast report earlier this year.
Takeda has unveiled more data from its phase 3 trials of zasocitinib, demonstrating that the once-daily pill was able to clear or almost clear scalp psoriasis in 75% of patients.
A phase 2 trial of InnoCare Pharma’s TYK2 inhibitor soficitinib in nonsegmental vitiligo has hit its primary endpoint, clearing the Chinese biotech to advance into the phase 3 part of the study.
A ballot measure to eliminate Missouri’s income tax would give the state legislature broad authority to levy new sales taxes to replace the lost revenue. Critics say that could mean adding a sales tax on medical services or prescription medicines. Those types of taxes are unusual, but not unheard of, in the U.S.